{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,14]],"date-time":"2025-05-14T05:22:26Z","timestamp":1747200146569,"version":"3.40.5"},"reference-count":29,"publisher":"Media Sphere Publishing House","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["S.S. Korsakov J. Neuro. Psych."],"published-print":{"date-parts":[[2023,5,4]]},"abstract":"<jats:p>Objective. Evaluation of the safety of psychopharmacotherapy (PFT) of mental disorders in modern protocols for the treatment of patients with blood disorders. Material and methods. The data of medical records of 552 patients with blood disorders who received PFT during treatment at the clinic of the National Medical Research Center for Hematology were analyzed. Any adverse events recorded while taking PFT were taken into account. Statistical analysis included descriptive statistics, frequency analysis, and assessment (Student\u2019s t-test) of changes in blood parameters (before and after taking psychotropic drugs). Results. Signs of hematotoxicity were found only in 7.1% (n=37) patients, in all cases while taking benzodiazepines (n=12) in combination with hematotoxic drugs for the treatment of blood disorders. Other significant adverse events (which caused premature discontinuation or dose reduction) were detected in 4.8% (n=25) cases, of which 9 were associated with the appointment of anxiolytics (hydroxyzine, zopiclone), 11 with antidepressants (clomipramine, amitriptyline, duloxetine, trazodone, ademethionine) and 5 with antipsychotics (risperidone, alimemazine, haloperidol). Conclusion. Most psychotropic drugs are effective in relation to psychopathological disorders that develop in hematological patients and are safe when used at minimum\/average therapeutic doses within the daily dosage ranges established by the official instructions for use.<\/jats:p>","DOI":"10.17116\/jnevro202312304290","type":"journal-article","created":{"date-parts":[[2023,5,4]],"date-time":"2023-05-04T16:57:40Z","timestamp":1683219460000},"page":"90","source":"Crossref","is-referenced-by-count":0,"special_numbering":"Vyp. 2","title":["Psychopharmacotherapy of mental disorders in hematological patients: security concerns"],"prefix":"10.17116","volume":"123","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7506-4947","authenticated-orcid":false,"given":"D.E.","family":"Vybornykh","sequence":"first","affiliation":[{"name":"National Medical Research Center for Hematology","place":["Moscow, Russia"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9532-7150","authenticated-orcid":false,"given":"S.V.","family":"Ivanov","sequence":"additional","affiliation":[{"name":"Mental Health Research Center","place":["Moscow, Russia"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8357-977X","authenticated-orcid":false,"given":"E.G.","family":"Gemdzhian","sequence":"additional","affiliation":[{"name":"National Medical Research Center for Hematology","place":["Moscow, Russia"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9684-5045","authenticated-orcid":false,"given":"T.V.","family":"Gaponova","sequence":"additional","affiliation":[{"name":"National Medical Research Center for Hematology","place":["Moscow, Russia"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"6743","reference":[{"unstructured":"Malignant neoplasms In Russia in 2020 (morbidity and mortality). Edited by Kaprin A.D., Starinsky V.V., Shakhzadova A.O. M.: MNIOI im. P.A. Herzen; 2021;252. (In Russ.)","key":"key-10.17116\/jnevro202312304290-1"},{"unstructured":"Vybornykh DE. Clinical and epidemiological study of a sample of patients with diseases of the blood system. Konsul\u2019tativnaja Psihologija i Psihoterapija. 2014;1(80):64-89. (In Russ.)","key":"key-10.17116\/jnevro202312304290-2"},{"doi-asserted-by":"publisher","key":"key-10.17116\/jnevro202312304290-3","DOI":"10.17116\/jnevro2021121052106"},{"unstructured":"Vybornykh D.E. Effect of psychotropic drugs on the hematopoietic system. Social\u2019naja i Klinicheskaja Psihiatrija. 2002;12(4):71-79. (In Russ.)","key":"key-10.17116\/jnevro202312304290-4"},{"doi-asserted-by":"publisher","key":"key-10.17116\/jnevro202312304290-5","DOI":"10.1016\/S0033-3182(86)72722-9"},{"doi-asserted-by":"publisher","key":"key-10.17116\/jnevro202312304290-6","DOI":"10.17116\/jnevro201911910151"},{"unstructured":"Mazaira S. Efectos adversos hematol\u00f3gicos de los psicof\u00e1rmacos [Haematological adverse effects caused by psychiatric drugs]. Vertex. 2008;19(82):378-386","key":"key-10.17116\/jnevro202312304290-7"},{"doi-asserted-by":"publisher","key":"key-10.17116\/jnevro202312304290-8","DOI":"10.1016\/j.jprot.2020.103813"},{"unstructured":"Vidal Handbook 2022. Medicines In Russia. Vidal Rus; 2022;1120. (In Russ.)","key":"key-10.17116\/jnevro202312304290-9"},{"doi-asserted-by":"crossref","unstructured":"Sirota P, Stoler M, Meshulam B. Major depression with psychotic features associated with acyclovir therapy. Drug Intell Clin Pharm. 1988;4(22):306-308","key":"key-10.17116\/jnevro202312304290-10","DOI":"10.1177\/106002808802200406"},{"doi-asserted-by":"publisher","key":"key-10.17116\/jnevro202312304290-11","DOI":"10.1176\/ajp.150.4.673a"},{"doi-asserted-by":"publisher","key":"key-10.17116\/jnevro202312304290-12","DOI":"10.3109\/15622970701624587"},{"doi-asserted-by":"publisher","key":"key-10.17116\/jnevro202312304290-13","DOI":"10.1002\/1099-1611(200005\/06)9:3<253::aid-pon449>3.0.co;2-c"},{"doi-asserted-by":"publisher","key":"key-10.17116\/jnevro202312304290-14","DOI":"10.1093\/jjco\/hyg097"},{"unstructured":"Ambanelli U, Manganelli P. Sifnificato clinico delle alterazioni del metabolismo del triptofano [Clinical significance of changes in tryptophan metabolism]. Ateneo Parmense Acta Biomed. 1975;46(1-2):5-19","key":"key-10.17116\/jnevro202312304290-15"},{"doi-asserted-by":"publisher","key":"key-10.17116\/jnevro202312304290-16","DOI":"10.1093\/schbul\/20.3.507"},{"unstructured":"Schr\u00f6der A, Weise K. Ein 20-j\u00e4hriger Schizophrener mit akuter Leuk\u00e4mie [A 20-year-old schizophrenic patient with acute leukemia]. Psychiatr Prax. 1996;23(3):145","key":"key-10.17116\/jnevro202312304290-17"},{"doi-asserted-by":"publisher","key":"key-10.17116\/jnevro202312304290-18","DOI":"10.1192\/pb.bp.114.048306"},{"doi-asserted-by":"publisher","key":"key-10.17116\/jnevro202312304290-19","DOI":"10.1111\/andr.12700"},{"doi-asserted-by":"publisher","key":"key-10.17116\/jnevro202312304290-20","DOI":"10.1016\/j.lrr.2021.100253"},{"doi-asserted-by":"publisher","key":"key-10.17116\/jnevro202312304290-21","DOI":"10.1023\/a:1012518831494"},{"unstructured":"Nazarenko GI, Kishkun AA. Clinical evaluation of laboratory results. M., 2005. (In Russ.)","key":"key-10.17116\/jnevro202312304290-22"},{"doi-asserted-by":"publisher","key":"key-10.17116\/jnevro202312304290-23","DOI":"10.3390\/toxics9020025"},{"doi-asserted-by":"publisher","key":"key-10.17116\/jnevro202312304290-24","DOI":"10.1111\/trf.13992"},{"doi-asserted-by":"crossref","unstructured":"Lopez-Vilchez I, Jerez-Dolz D, Diaz-Ricart M, et al. Escitalopram Impairs Thrombin-Induced Platelet Response, Cytoskeletal Assembly and Activation of Associated Signalling Pathways. Thromb Haemost. 2017;117(12):2312-2321","key":"key-10.17116\/jnevro202312304290-25","DOI":"10.1160\/TH17-04-0288"},{"doi-asserted-by":"publisher","key":"key-10.17116\/jnevro202312304290-26","DOI":"10.1213\/ANE.0000000000002668"},{"doi-asserted-by":"publisher","key":"key-10.17116\/jnevro202312304290-27","DOI":"10.1016\/j.arth.2019.04.057"},{"doi-asserted-by":"publisher","key":"key-10.17116\/jnevro202312304290-28","DOI":"10.1038\/s41598-019-56487-8"},{"doi-asserted-by":"publisher","key":"key-10.17116\/jnevro202312304290-29","DOI":"10.1016\/j.hlc.2019.07.011"}],"container-title":["S.S. Korsakov Journal of Neurology and Psychiatry"],"original-title":[],"language":"en","deposited":{"date-parts":[[2025,4,24]],"date-time":"2025-04-24T10:30:59Z","timestamp":1745490659000},"score":1,"resource":{"primary":{"URL":"https:\/\/mediasphera.ru\/issues\/zhurnal-nevrologii-i-psikhiatrii-im-s-s-korsakova-2\/2023\/4-2\/1199772982023042090"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5,4]]},"references-count":29,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2023,5,4]]}},"alternative-id":["10.17116\/jnevro202312304290"],"URL":"https:\/\/doi.org\/10.17116\/jnevro202312304290","relation":{},"ISSN":["1997-7298"],"issn-type":[{"type":"print","value":"1997-7298"}],"subject":[],"published":{"date-parts":[[2023,5,4]]}}}